2024
DOI: 10.1097/bor.0000000000001016
|View full text |Cite
|
Sign up to set email alerts
|

Drug therapy in juvenile spondyloarthritis

Hemalatha Srinivasalu,
Jessica Simpson,
Matthew L. Stoll

Abstract: Purpose of review This review summarizes latest developments in treatment of juvenile spondyloarthritis (JSpA), specifically enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA). Recent findings There has been addition of biologic disease modifying antirheumatic drugs (bDMARDs) beyond tumor necrosis factor inhibitors (TNFi) for JSpA such as IL-17 blockers, IL-23 blockers, and janus activating kinase inhibitors with favorable safety… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 48 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?